Picture of Pfizer logo

PFE — Pfizer News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapSuper Stock

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

- Pfizer PFE.N beat Wall Street estimates for second-quarter profit on Tuesday, driven by strong demand for its blood thinner, Eliquis.

On an adjusted basis, the company reported a profit of 77 cents per share, compared with analysts' estimates of 68 cents per share, according to data compiled by LSEG.


(Reporting by Mariam Sunny and Mrinalika Roy in Bengaluru; Editing by Anil D'Silva)

((Mariam.ESunny@thomsonreuters.com;))

Recent news on Pfizer

See all news